Global Information
회사소개 | 문의 | 위시리스트

개방각녹내장(OAG) : 역학 예측(2028년)

Open-angle glaucoma (OAG) - Epidemiology Forecast - 2028

리서치사 DelveInsight Business Research LLP
발행일 2019년 11월 상품 코드 534932
페이지 정보 영문 60 Pages
가격
US $ 3,250 ₩ 3,831,000 PDF by E-mail (Single User License)
US $ 6,500 ₩ 7,662,000 PDF by E-mail (Site License)
US $ 9,750 ₩ 11,493,000 PDF by E-mail (Global License)


개방각녹내장(OAG) : 역학 예측(2028년) Open-angle glaucoma (OAG) - Epidemiology Forecast - 2028
발행일 : 2019년 11월 페이지 정보 : 영문 60 Pages

주요 7개국(미국, 영국, 독일, 프랑스, 이탈리아, 스페인, 일본)에서 개방각녹내장(OAG : Open-angle glaucoma)의 2017년 유병 수는 981만 9,080명으로 추산되고 있습니다.

주요 7개국(미국, 영국, 독일, 프랑스, 이탈리아, 스페인, 일본)의 개방각녹내장(OAG) 시장을 조사했으며, 질병 개요 및 국가별 역학, 병형·임상 증상별 유병 수의 추이와 예측을 정리하여 전해드립니다.

목차

제1장 주요 인사이트

제2장 개방각녹내장(OAG) 시장의 개요

  • 개방각녹내장(OAG)의 시장 점유율(실적)
  • 개방각녹내장(OAG)의 시장 점유율(예측)

제3장 질병 배경과 개요 : 개방각녹내장(OAG)

  • 서론
  • 분류
  • 징후와 증상
  • 위험인자
  • 임상 증상
  • 유전적 기반
    • 마이오실린(MYOC, OMIM #601652)
    • 옵티뉴린(OPTN, OMIM #602432)
    • TANK 결합 키나아제-1(TANK-binding Kinase-1)
    • WD 리피트 36(WDR36, OMIM 609669)
  • 진단

제4장 역학과 환자 인구

  • 주요 조사 결과
  • 주요 7개국의 개방각녹내장(OAG) 총유병 수
  • 주요 7개국의 개방각녹내장(OAG) 진단 수

제5장 미국 개방각녹내장(OAG)의 역학

  • 개방각녹내장(OAG)의 총유병 수
  • 개방각녹내장(OAG)의 진단 수
  • 개방각녹내장(OAG)의 유병 수 : 성별
  • 개방각녹내장(OAG)의 유병 수 : 연령별
  • 개방각녹내장(OAG)의 유병 수 : 병형별

제6장 EU 5개국 개방각녹내장(OAG)의 역학

  • 독일
    • 개방각녹내장(OAG)의 총유병 수
    • 개방각녹내장(OAG)의 진단 수
    • 개방각녹내장(OAG)의 유병 수 : 성별
    • 개방각녹내장(OAG)의 유병 수 : 연령별
    • 개방각녹내장(OAG)의 유병 수 : 병형별
  • 프랑스
    • 개방각녹내장(OAG)의 총유병 수
    • 개방각녹내장(OAG)의 진단 수
    • 개방각녹내장(OAG)의 유병 수 : 성별
    • 개방각녹내장(OAG)의 유병 수 : 연령별
    • 개방각녹내장(OAG)의 유병 수 : 병형별
  • 이탈리아
    • 개방각녹내장(OAG)의 총유병 수
    • 개방각녹내장(OAG)의 진단 수
    • 개방각녹내장(OAG)의 유병 수 : 성별
    • 개방각녹내장(OAG)의 유병 수 : 연령별
    • 개방각녹내장(OAG)의 유병 수 : 병형별
  • 스페인
    • 개방각녹내장(OAG)의 총유병 수
    • 개방각녹내장(OAG)의 진단 수
    • 개방각녹내장(OAG)의 유병 수 : 성별
    • 개방각녹내장(OAG)의 유병 수 : 연령별
    • 개방각녹내장(OAG)의 유병 수 : 병형별
  • 영국
    • 개방각녹내장(OAG)의 총유병 수
    • 개방각녹내장(OAG)의 진단 수
    • 개방각녹내장(OAG)의 유병 수 : 성별
    • 개방각녹내장(OAG)의 유병 수 : 연령별
    • 개방각녹내장(OAG)의 유병 수 : 병형별

제7장 일본 개방각녹내장(OAG)의 역학

  • 개방각녹내장(OAG)의 총유병 수
  • 개방각녹내장(OAG)의 진단 수
  • 개방각녹내장(OAG)의 유병 수 : 성별
  • 개방각녹내장(OAG)의 유병 수 : 연령별
  • 개방각녹내장(OAG)의 유병 수 : 병형별

제8장 부록

제9장 DelveInsight의 서비스 내용

제10장 면책사항

제11장 DelveInsight 소개

KSA 19.11.08

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

List of Tables

Table 1 Clinical Stages of Primary Open-Angle Glaucoma

Table 2 Two Classes of Primary Open-Angle Glaucoma (POAG) Mutations

Table 3 Total Prevalence of Glaucoma in the 7MM (2017-2028)

Table 4 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the 7MM (2017-2028)

Table 5 Total Prevalence of Glaucoma in the United States (2017-2028)

Table 6 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the US (2017-2028)

Table 7 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in the US (2017-2028)

Table 8 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States(2017-2028)

Table 9 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States (2017-2028)

Table 10 Total Prevalence of Glaucoma in Germany (2017-2028)

Table 11 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Germany (2017-2028)

Table 12 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany (2017-2028)

Table 13 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany (2017-2028)

Table 14 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany (2017-2028)

Table 15 Total Prevalence of Glaucoma in France (2017-2028)

Table 16 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in France (2017-2028)

Table 17 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in France (2017-2028)

Table 18 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in France (2017-2028)

Table 19 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in France (2017-2028)

Table 20 Total Prevalence of Glaucoma in the Italy (2017-2028)

Table 21 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Italy (2017-2028)

Table 22 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy (2017-2028)

Table 23 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy (2017-2028)

Table 24 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy (2017-2028)

Table 25 Total Prevalence of Glaucoma in the Spain (2017-2028)

Table 26 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Spain (2017-2028)

Table 27 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain (2017-2028)

Table 28 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain (2017-2028)

Table 29 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain (2017-2028)

Table 30 Total Prevalence of Glaucoma in the United Kingdom (2017-2028)

Table 31 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Table 32 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Table 33 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Table 34 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Table 35 Total Prevalence of Glaucoma in Japan (2017-2028)

Table 36 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Japan (2017-2028)

Table 37 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan (2017-2028)

Table 38 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan (2017-2028)

Table 39 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan (2017-2028)

List of Figures

Figure 1 Open-Angle in Glaucoma

Figure 2 Development of Glaucoma

Figure 3 Classification of Open-Angle Glaucoma

Figure 4 Symptoms of Open-Angle Glaucoma

Figure 5 Risk Factors Associated with Open-Angle Glaucoma

Figure 6 Factors Contributing to the Pathophysiology of Glaucomatous Neurodegeneration

Figure 7 Pathophysiology of Primary Open-Angle Glaucoma

Figure 8 Diagnosis of Primary Open-Angle Glaucoma (POAG)

Figure 9 Glaucoma Assessment (Optic Nerve)

Figure 10 Total Prevalence of Glaucoma in the 7MM (2017-2028)

Figure 11 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the 7MM (2017-2028)

Figure 12 Total Prevalence of Glaucoma in the United States (2017-2028)

Figure 13 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the US (2017-2028)

Figure 14 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in the US (2017-2028)

Figure 15 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States (2017-2028)

Figure 16 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States (2017-2028)

Figure 17 Total Prevalence of Glaucoma in Germany (2017-2028)

Figure 18 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Germany (2017-2028)

Figure 19 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany (2017-2028)

Figure 20 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany (2017-2028)

Figure 21 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany (2017-2028)

Figure 22 Total Prevalence of Glaucoma in France (2017-2028)

Figure 23 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in France (2017-2028)

Figure 24 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in France (2017-2028)

Figure 25 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in France (2017-2028)

Figure 26 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in France (2017-2028)

Figure 27 Total Prevalence of Glaucoma in Italy (2017-2028)

Figure 28 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Italy (2017-2028)

Figure 29 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy (2017-2028)

Figure 30 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy (2017-2028)

Figure 31 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy (2017-2028)

Figure 32 Total Prevalence of Glaucoma in Spain (2017-2028)

Figure 33 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Spain (2017-2028)

Figure 34 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain (2017-2028)

Figure 35 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain (2017-2028)

Figure 36 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain (2017-2028)

Figure 37 Total Prevalence of Glaucoma in the United Kingdom (2017-2028)

Figure 38 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Figure 39 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Figure 40 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Figure 41 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom (2017-2028)

Figure 42 Total Prevalence of Glaucoma in Japan (2017-2028)

Figure 43 Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Japan (2017-2028)

Figure 44 Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan (2017-2028)

Figure 45 Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan (2017-2028)

Figure 46 Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan (2017-2028)

DelveInsight's Open-angle glaucoma (OAG) - Epidemiology-2028 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of OAG in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2028

Open-angle glaucoma (OAG) - Disease Understanding and Treatment Algorithm

Open-angle glaucoma (OAG) is a progressive form of glaucoma in which the channel formed between the iris and the cornea remains open and tissue changes along the channel, which gradually reduces the drainage of the aqueous humor through the trabecular meshwork of the eye's anterior chamber. It is the most common form of glaucoma which accounts for majority of the glaucoma cases. The term "Open-Angle" refers to the angle where the iris meets the cornea and is as wide and open as it should be. OAG is mainly caused by the slow clogging of the drainage canals, resulting in increased eye pressure.

In OAG, there are characteristic optic nerve changes (damage) associated with open angles (the area between the iris and cornea) and elevated eye pressure. The risk factors associated with open-angle glaucoma include elevated intraocular pressure (IOP), age >60 years, genetic predisposition, certain eye characteristics (such as a pupillary defect, thin cornea, myopia), low educational status, smoking, African descent, and visual problems (such as ocular hypertension, larger horizontal or vertical cup disc ratio, greater Humphrey visual field pattern deviation, asymmetries in the visual field, and IOP).

The OAG is primarily divided into two subtypes, i.e., Primary OAG and Secondary OAG. The risk factors of open-angle glaucoma are divided into four categories, general factors, ocular factors, nonocular factors, and ocular hypertension.

DelveInsight's Open-angle glaucoma (OAG) epidemiology report gives a thorough understanding of the OAG by including details, such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends.

Open-angle glaucoma (OAG) - Epidemiology

The Open-angle glaucoma (OAG) epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders (KOL). This part of the DelveInsight's report also provides the diagnosed patient pool and their trends along with undertaken assumptions.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented by Total Prevalence of Glaucoma in the 7MM, Total Diagnosed Prevalent Population of Open-Angle Glaucoma , Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma, Age - Specific Diagnosed Prevalence of Open-Angle Glaucoma and Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma] scenario of OAG in the 7MM Countries covering United States, EU5 countries (Germany, Spain, Italy, France, and United Kingdom), and Japan from 2017 to 2028.

As per DelveInsight's analysis, a higher percentage of diagnosed prevalence of OAG was observed for females, in comparison to males, in all the 7MM countries. DelveInsight's analysts have assessed that the total prevalent population of Glaucoma in the 7MM was 9,819,080 in 2017. In addition to this it was also assessed that among those with glaucoma in the 7MM, more than 8.5 million were diagnosed with OAG. DelveInsight's estimate suggests that the United States witnessed highest number of cases with OAG, as compared to other 7MM countries. As per DelveInsight's estimates, the country accounted for approximately 2,749,378 cases in 2017.

Among the EU-5 countries, Germany accounted for the highest number of glaucoma cases in 2017, which was observed to be equivalent to more than 25% of the total affected population in this region. The number of cases for glaucoma was observed to be 1,041,889 in the country for 2017. However, Spain accounted for the lowest number of glaucoma cases in 2017, which was approximately 13.33% of the total affected population of EU-5 countries. According to the DelveInsight's analysts, Japan accounted for second-highest number of OAG patients, i.e., 28.79% of the total OAG population in the 7MM countries. According to DelveInsight's assessment, it has been observed that OAG prevalence varied across the 7MM countries, based on age-specific prevalence of the disease. For instance, the highest proportion was observed in 70-79 years age group in the US, while in the EU-5 countries, people aged ≥80 years accounted for the maximum patient pool. In contrast, middle age population aged 40-49 years contributed highest patient pool in Japan.

Report Scope

  • The report covers a detailed overview of Open-angle glaucoma explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool for seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Open-angle glaucoma
  • The report helps to recognize the growth opportunities in the 7MM countries with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology by total Prevalence of Glaucoma in the 7MM, Total Diagnosed Prevalent Population of Open-Angle Glaucoma, Gender-Specific Diagnosed Prevalence, Age - Specific Diagnosed Prevalence and Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma.

Open-angle glaucoma Report Key Strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Prevalence of Glaucoma
  • Total Diagnosed Prevalent Population of Open-Angle Glaucoma
  • Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma
  • Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma
  • Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma

Open-angle glaucoma Report Assessment

  • Patient segmentation
  • Disease risk and burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Open-Angle Glaucoma (OAG): Epidemiology Overview at a Glance

  • 2.1. Total Epidemiology Share (%) Distribution of OAG in 2017
  • 2.2. Total Epidemiology Share (%) Distribution of OAG in 2028

3. Open-Angle Glaucoma: Disease Background and Overview

  • 3.1. Introduction
  • 3.2. Classification of Open-Angle Glaucoma
  • 3.3. Signs and Symptoms of Open-Angle Glaucoma
  • 3.4. Risk Factors of Open-Angle Glaucoma
    • 3.4.1. General
    • 3.4.2. Ocular
    • 3.4.3. Nonocular
    • 3.4.4. Ocular Hypertension
  • 3.5. Pathophysiology of Open-Angle Glaucoma
  • 3.6. Genes Involved in Primary Open-Angle Glaucoma
    • 3.6.1. Myocilin (MYOC, OMIM #601652)
    • 3.6.2. Optineurin (OPTN, OMIM #602432)
    • 3.6.3. TANK-binding Kinase-1 (TBK1)
    • 3.6.4. WD-repeat domain 36 (WDR36, OMIM 609669)
  • 3.7. Diagnosis of Open-Angle Glaucoma
    • 3.7.1. Diagnosis of Primary Open-Angle Glaucoma
    • 3.7.2. Diagnosis of Secondary Open-Angle Glaucoma

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalence of Glaucoma in the 7MM
  • 4.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the 7MM

5. United States Epidemiology

  • 5.1. 38
  • 5.2. Total Prevalence of Glaucoma in the United States
  • 5.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the United States
  • 5.4. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States
  • 5.5. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States
  • 5.6. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United States

6. EU5 Epidemiology

  • 6.1. Germany Epidemiology
    • 6.1.1. Assumptions and Rationale
    • 6.1.2. Total Prevalence of Glaucoma in Germany
    • 6.1.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Germany
    • 6.1.4. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany
    • 6.1.5. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany
    • 6.1.6. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Germany
  • 6.2. France Epidemiology
    • 6.2.1. Assumptions and rationale
    • 6.2.2. Total Prevalence of Glaucoma in France
    • 6.2.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in France
    • 6.2.4. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in France
    • 6.2.5. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in France
    • 6.2.6. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in France
  • 6.3. Italy Epidemiology
    • 6.3.1. Assumptions and Rationale
    • 6.3.2. Total Prevalence of Glaucoma in Italy
    • 6.3.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Italy
    • 6.3.4. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy
    • 6.3.5. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy
    • 6.3.6. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Italy
  • 6.4. Spain Epidemiology
    • 6.4.1. Assumptions and Rationale
    • 6.4.2. Total Prevalence of Glaucoma in Spain
    • 6.4.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Spain
    • 6.4.4. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain
    • 6.4.5. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain
    • 6.4.6. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Spain
  • 6.5. United Kingdom Epidemiology
    • 6.5.1. Assumptions and Rationale
    • 6.5.2. Total Prevalence of Glaucoma in the United Kingdom
    • 6.5.3. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in the United Kingdom
    • 6.5.4. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom
    • 6.5.5. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom
    • 6.5.6. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in the United Kingdom

7. Japan Epidemiology

  • 7.1. Assumptions and Rationale
    • 7.1.1. Total Prevalence of Glaucoma in Japan
    • 7.1.2. Total Diagnosed Prevalent Population of Open-Angle Glaucoma in Japan
    • 7.1.3. Gender- Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan
    • 7.1.4. Age-Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan
    • 7.1.5. Type - Specific Diagnosed Prevalence of Open-Angle Glaucoma in Japan

8. Appendix

  • 8.1. Report Methodology

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Back to Top
전화 문의
F A Q